(19)
(11) EP 1 986 619 A2

(12)

(88) Date of publication A3:
04.09.2008

(43) Date of publication:
05.11.2008 Bulletin 2008/45

(21) Application number: 07763614.0

(22) Date of filing: 06.02.2007
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
(86) International application number:
PCT/US2007/003095
(87) International publication number:
WO 2007/092414 (16.08.2007 Gazette 2007/33)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 06.02.2006 US 771163 P
02.05.2006 US 797201 P

(71) Applicants:
  • Lixte Biotechnology Holdings, Inc.
    East Setauket, NY 11733 (US)
  • THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Rockville, MD 20852-3804 (US)

(72) Inventors:
  • ZHUANG, Zhengping
    Bethesda, MD 20814 (US)
  • OLDFIELD, Edward, H.
    Philomont, VA 20131-0309 (US)
  • PARK, Deric, M.
    Bethesda, MD 20817 (US)
  • LUBENSKY, Irina
    Potomac, MD 20854 (US)
  • LI, Jie
    Gaithersburg, MD 20878-1329 (US)
  • KOVACH, John, S.
    East Setauket, NY 11733 (US)

(74) Representative: Müller Fottner Steinecke 
Rechtsanwälte Patentanwälte Postfach 31 01 40
80102 München
80102 München (DE)

   


(54) USE OF PHOSPHATASES TO TREAT TUMORS OVEREXPRESSING N-COR